Multivariable logistic regression to assess covariates for continued SAM (BMI z score less than −3.0) at the study end point in participants with SCA and SAM in the SAMS trial allocated to receive RUTF with or without moderate-dose hydroxyurea (20 mg/kg per day) for 12 weeks
| Variable . | OR . | 95% CI . | P value . |
|---|---|---|---|
| Age, y | 1.258 | 1.009-1.568 | .041 |
| Sex (female) | 1.310 | 0.551-3.110 | .541 |
| Hb | 1.174 | 0.769-1.792 | .458 |
| Baseline BMI z score | 0.155 | 0.051-0.474 | .001 |
| Group (RUTF plus hydroxyurea) | 0.666 | 0.281-1.582 | .357 |
| Variable . | OR . | 95% CI . | P value . |
|---|---|---|---|
| Age, y | 1.258 | 1.009-1.568 | .041 |
| Sex (female) | 1.310 | 0.551-3.110 | .541 |
| Hb | 1.174 | 0.769-1.792 | .458 |
| Baseline BMI z score | 0.155 | 0.051-0.474 | .001 |
| Group (RUTF plus hydroxyurea) | 0.666 | 0.281-1.582 | .357 |